Physician profile
Armando Garza
NPI 1679573836
$1,287.21
in general payments reported to CMS, 2019-2025
18 companies · $14.44 in 2025
The $14.44 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.96 · 2020: $145 · 2021: $318 · 2022: $119 · 2023: $325 · 2024: $273 · 2025: $14.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $232.62 | 2021-2024 | Azstarys |
| Tris Pharma INC | $216.73 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $183.80 | 2021-2024 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $143.58 | 2021-2024 | Gardasil 9, Gardasil, Vaxneuvance |
| Fresenius Kabi USA, LLC | $125.00 | 2023 | Smoflipid |
| Sanofi Pasteur INC. | $59.06 | 2019-2023 | |
| Ironshore Pharmaceuticals INC. | $52.40 | 2019-2023 | Jornay Pm |
| Shire North American Group INC | $41.95 | 2019 | |
| Cranial Technologies, INC | $36.63 | 2021 | |
| Glaxosmithkline, LLC. | $31.55 | 2021-2025 | Pediarix, Rotarix, Bexsero |
| Organon LLC | $29.36 | 2024 | |
| Hologic Sales and Service, LLC | $28.15 | 2023 | Aptima |
| Mayne Pharma Commercial LLC | $23.78 | 2021 | |
| Lupin INC. | $18.70 | 2021 | |
| Verrica Pharmaceuticals INC. | $18.56 | 2024 | Ycanth |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.33 | 2024 | |
| Genentech USA, INC. | $15.56 | 2020 | |
| Therapeuticsmd, INC. | $12.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armando Garza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.